XML 63 R45.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders’ Equity (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Feb. 07, 2024
Dec. 31, 2022
Sep. 30, 2022
Aug. 01, 2022
Apr. 30, 2022
Mar. 11, 2022
Feb. 08, 2022
Dec. 28, 2021
Aug. 12, 2016
Aug. 31, 2022
Apr. 30, 2022
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Aug. 13, 2024
Sep. 30, 2023
 [1]
Aug. 31, 2023
Jan. 31, 2023
Jan. 11, 2023
Apr. 29, 2022
Mar. 09, 2021
Dec. 31, 2018
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Common stock issued for conversion of convertible debt, shares                                 297,625 105                  
Debt, principal                             $ 558,628                        
Accrued interest settled with common stock                                   $ 16,340                  
Loss on settlement of convertible debt                         $ 415,553 71,315 $ 433,807 $ 477,221 $ 1,795,652                  
Number of warrants to purchase               62,500                             127,260        
Exercise price per share   $ 111.04   $ 20.00 $ 8.00     $ 8.00   $ 16.00 $ 8.00             $ 111.04 $ 8.00       $ 18.80   $ 16.00    
Aggregate intrinsic value of warrants                       0     0                        
Number of shares vested under plan                                 60,048                    
Restricted stock award granted value                                              
Share based compensation                             182,611 57,855 181,960 $ 237,547                  
Sale of stock consideration received per transaction $ 2,250,000                                                    
Share based compensation arrangement by share based payment award description (i) one share of the Company’s common stock, (ii) a warrant to purchase one share of the Company’s common stock exercisable at a purchase price of $18.80 per share, and (iii) a percentage of equity interest in Diagnostics such that, assuming the sale of all $2,250,000 of Units, SRO LLC will own a 22% interest in Diagnostics.                                                    
Proceeds from issuance of common stock $ 4,500,000                                                    
Direct cost                             $ 142,000                        
Common stock vesting of restricted stock unit                                   3,500                  
Number shares issued for conversion of note, shares                                   42,113                  
Number shares issued for conversion dividends payable, shares                                   12,553                  
Shares exercised     62,500                             62,500                  
Gain (Loss) on Sale of Assets and Asset Impairment Charges                                   $ 1,198,438                  
Change in fair value of warrant liabilities, as restated       $ 146,624                         398,675                  
Common stock issued for cash upon initial public offering and exercise of warrants, net of issuance costs, as restated     $ 2,031,250                             $ 9,951,356 $ 2,031,249                
Stock issued for cash, shares                                   3,750                  
Preferred stock value share   0.00001                   $ 0.00001     $ 0.00001   $ 0.00001 $ 0.00001   $ 0.00001              
Exercise price       $ 32.00 $ 32.00     $ 40.00   $ 32.50               $ 32.00                  
Deemed dividend                                   $ 439,427                  
Share price   16.00                               $ 16.00       $ 1.00   $ 18.80      
Deemed contribution                                   $ 31,423                  
Stock issued for conversion, vallue                                                    
Warrants description                                   The Series A Preferred Stock sold in the Company’s 2018 and 2019 private placement offerings included warrants to be issued upon the earlier of a closing of the sale of shares of common stock to the public or upon a listing of the Company’s common stock. The warrants will be exercisable for a period of three years after the date of issuance at an exercise price contingent on the terms of the public offering. The initial form of the warrants were expected to include contingent call features based on the terms of the public offering. As originally drafted, if an initial public offering occurs at a price at or above $111.04, then the warrants are callable if the 20-day VWAP of the common stock in at or above 150% of the variable exercise price. In the scenario where the common stock is listed with a common stock issuance price below $111.04, then the warrants are callable if the 20-day VWAP of the common stock is at or above the $166.56 exercise price. Upon the issuance of the warrants in September 2022, the contingent call features were not included in the agreements. Given the variability in the number of warrants and exercise price, the detachable warrants contained terms and features that gave rise to liability classification.                  
Warrant share price   $ 166.56                               $ 166.56                  
Additional paid in capital   $ 26,518,433                   $ 29,996,963     $ 29,996,963   $ 29,489,055 $ 26,518,433 $ 12,063,940   $ 29,402,533            
Interest rate               10.00%   10.00%                               1.00%  
Warrant term                   4 years 6 months                                  
Volatility rate   86.10%   80.00% 83.60%     86.30%   82.50%                                  
Risk free rate       2.66% 2.55%     1.27%   3.43%                                  
Four year warrant to purchase         62,500           62,500                                
Aggregate intrinsic value of warrants                                 0                    
Minimum [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Stock issued for cash, shares                     10,000,000                                
Exercise price                     $ 99.92                                
Risk free rate                                   1.81%                  
Maximum [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Exercise price                     $ 40.00                                
Risk free rate                                   1.96%                  
Series A Preferred Stock [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Cumulative dividends percentage                                   8.50%                  
Preferred stock value share   $ 1,000                               $ 1,000                  
Additional paid in capital   $ 756,723                               $ 756,723                  
Warrants liability   0                               0                  
Warrants obligation liability   $ 421,768                               $ 421,768                  
Boustead Securities LLC [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Debt, principal                       $ 0   1,527,750 $ 235,200 1,593,900 $ 1,925,700                    
Number of warrants to purchase   22,535                   8,909     8,909   8,909 22,535                  
Exercise price per share       $ 20.00           $ 97.52   $ 18.80     $ 18.80   $ 18.80                    
Change in fair value of warrant liabilities, as restated                             $ 99,543   $ 99,543                    
Exercise price       32.00                                              
Share price       $ 20.00                                              
Interest rate   10.00%                               10.00%                  
Volatility rate       80.00%                                              
Risk free rate       2.66%                                              
Issuance of warrants shares       625                                              
IPO [Member] | Series A Preferred Stock [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Cumulative dividends, shares                                   1,213                  
Cumulative dividends percentage                                   8.50%                  
Conversion price percentage   90                               90                  
Share price   $ 32.00                               $ 32.00                  
conversion price   $ 28.80                               $ 28.80                  
Cumulative dividends   $ 71,009                               $ 71,009                  
Stock issued for conversion, vallue                                   $ 402,064                  
IPO [Member] | Common Stock [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Stock issued for cash, shares                                   42,113                  
Purchase Agreement [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Escrow deposit 2,250,000                                                    
Right offering 4,500,000                                                    
Escrow deposit $ 2,250,000                                                    
Initial public offering description Unless the parties waive the conditions to closing, in the event the full $4,500,000 is not raised, whether through SRO LLC or through the Company’s existing stockholders, the Company will not close on the offering and any funds raised and held in escrow will be returned to investors                                                    
Commitment fee $ 112,500                                                    
Related expense $ 40,000                                                    
Research and Development Expense [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Share based compensation                       $ 100,000   300,000 200,000 600,000 66,960 $ 131,965                  
Compensation under research and development                       13,033   $ 41,190 46,986 41,190                      
Restricted Stock Units (RSUs) [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Share based compensation                             182,611 $ 57,855                      
Unrecognized compensation cost                       $ 190,779     $ 190,779                        
Weighted average term                             1 year 11 months 19 days                        
Unrecognized compensation cost   $ 61,111                             $ 231,550 $ 61,111                  
Weighted Average Life (Years), Outstanding Ending                                 1 year 21 days 1 year 9 months 29 days                  
Restricted Stock Units (RSUs) [Member] | Directors And Officers [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Restricted stock award granted shares                       28,455   4,291 53,455 7,416                      
Restricted stock award granted value                       $ 100,000   $ 47,400 $ 141,840 $ 95,400                      
Restricted Stock Units (RSUs) [Member] | Directors Officers and Consultants [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Restricted stock award granted shares                                 32,415 4,449                  
Restricted stock award granted value                                 $ 352,400 $ 100,000                  
Restricted Stock [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Common stock issued for conversion of convertible debt, shares                                 10,650                    
2018 Equity Incentive Plan [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Common stock reserved for future issuance                                 3,000,000                   3,000,000
Share granted under equity incentive plan                       138,234     138,234   84,779                    
Number of shares vested under plan                             79,395                        
Alto Convertible Note [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Number of warrants to purchase                                             8,909        
Exercise price per share                                             $ 18.80        
2022 Convertible Note Derivative [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Shares exercised                                   18,438                  
Change in fair value of warrant liabilities, as restated                                   $ 1,475                  
December 2021 Notes [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Number of warrants to purchase   66,250                               66,250                  
August 2022 Notes [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Change in fair value of warrant liabilities, as restated                                   $ 121,875                  
2022 Convertible Bridge Notes [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Exercise price per share   $ 0.08                               $ 0.08                  
Commitment fee           $ 64,285 $ 64,285                                        
conversion price   $ 32.00                               $ 32.00                  
Interest rate           6.00% 6.00%                                        
2022 Convertible Bridge Notes [Member] | Boustead Securities LLC [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Number of warrants to purchase   2,582               2,582               2,582                  
Exercise price per share   $ 16.00               $ 16.00               $ 16.00                  
Change in fair value of warrant liabilities, as restated                                   $ 92,336                  
Interest rate           10.00% 10.00%                                        
Common Stock [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Common stock issued for conversion of convertible debt, shares                       0   228,489 78,197 234,864   36,876                  
Debt, principal                       $ 0   $ 1,527,750 $ 235,200 $ 1,593,900 $ 1,925,700                    
Accrued interest settled with common stock                       0   220,689 18,783 240,831 294,927                    
Loss on settlement of convertible debt                       $ 0   $ 415,553 $ 71,315 $ 433,807 $ 477,221                    
Restricted stock award granted shares                       3,722 15,625   19,347   10,650 3,500                  
Restricted stock award granted value                                              
Common stock issued for dividends payable                                   $ 402,064                  
Cumulative dividends, shares                                   105                  
Conversion of Stock, Shares Issued                 5,625,000                                    
Common stock issued for cash upon initial public offering and exercise of warrants, net of issuance costs, as restated                                   $ 4                  
Stock issued for cash, shares                       0   228,489 78,197 234,864 297,625 352,443                  
Share price   $ 32.00                               $ 32.00                  
Stock issued for conversion, vallue                                                    
Common Stock [Member] | IPO [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Number of warrants to purchase   42,113                               42,113                  
Stock issued upon completion                                   $ 9,951,356                  
Cumulative dividends, shares                                   12,553                  
Four year warrant to purchase                   21,453                                  
Common Stock [Member] | Over-Allotment Option [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Exercise price per share                   $ 97.52                                  
Change in fair value of warrant liabilities, as restated                   $ 111,296                                  
Exercise price                   $ 50.88                                  
Warrant term                   5 years                                  
Volatility rate                   101.40%                                  
Risk free rate                   3.74%                                  
Four year warrant to purchase                   3,218                                  
Common Stock [Member] | Black Scholes Model [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Exercise price per share                   $ 97.52                                  
Change in fair value of warrant liabilities, as restated                   $ 426,752                                  
Exercise price                   $ 32.50                                  
Warrant term                   5 years                                  
Volatility rate                   101.80%                                  
Risk free rate                   3.27%                                  
Common Stock [Member] | 2022 Convertible Note Derivative [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Cumulative dividends, shares                                   36,876                  
Conversion of Stock, Shares Issued                                   18,438                  
Warrant [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Common stock issued for cash, shares                                   352,443                  
Warrant Liability Boustead Placement Agent Warrants [Member]                                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                      
Warrant liabilities exercised                   $ 64,140                                
[1] The Reverse Stock Split (Note 1) also resulted in an adjustment to the condensed consolidated balance sheet for the period ended September 30, 2023 with an increase to additional paid in capital of $140 and an offsetting adjustment to the carrying value of common stock.